US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Basilea Pharmaceutica AG

60.28

0.0000

Volume:- -

Turnover:- -

Market Cap:730.60M

PE:-1.00K

High:60.28

Open:60.28

Low:60.28

Close:60.28

52wk High:74.00

52wk Low:59.29

Shares:12.12M

Float Shares:12.11M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0602

EPS(LYR):1.04

ROE:38.52%

ROA:12.10%

PB:4.56

PE(LYR):58.24

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Basilea Pharmaceutica AG

Exchange:

PINK LIMITED

Establishment Date:

2000

Employees:

189

Office Location:

Hegenheimermattweg 167b,Allschwil,Switzerland

Website:

http://www.basilea.com/

Zip Code:

4123

Phone:

41 61 606 11 11

Fax:

- -

Introduction:

Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union. It also offers medicine drug for invasive fungal infections. In addition, the company provides Zevtera, an antibiotic for the treatment of community and hospital-acquired pneumonia, as well as offers treatment of acute bacterial skin and skin structure infections, and Staphylococcus aureus bacteremia. Further, it offers Fosmanogepix, an antifungal drug for the treatment of Candidemia which in Phase II clinical trials. Basilea Pharmaceutica AG was founded in 2000 and is headquartered in Allschwil, Switzerland.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BPMUF/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BPMUF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BPMUF\",,,,,undefined,":{"symbol":"BPMUF","market":"US","secType":"STK","nameCN":"Basilea Pharmaceutica AG","latestPrice":60.275,"timestamp":1781726400000,"preClose":60.275,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":12114554,"shares":12121130,"eps":-0.060238,"marketStatus":"Closed","change":0,"latestTime":"06-17 16:00:00 EDT Delay","open":60.275,"high":60.275,"low":60.275,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.060238,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1781769600000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1533355200000,"exchange":"PINK LIMITED","adjPreClose":60.275,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BPMUF\",,,,,undefined,":{"symbol":"BPMUF","floatShares":12114554,"roa":"12.10%","roe":"38.52%","lyrEps":1.035011,"shares":12121130,"dividePrice":0,"high":60.275,"amplitude":0,"preClose":60.275,"low":60.275,"week52Low":59.29,"pbRate":"4.56","psRate":"2.51","week52High":74,"institutionHeld":0,"latestPrice":60.275,"eps":-0.060238,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.060238,"open":60.275,"prevYearClose":63.25,"prevWeekClose":60.275,"prevMonthClose":65.1,"prevQuarterClose":71,"fiveDayClose":60.275,"twentyDayClose":65.1,"sixtyDayClose":71},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BPMUF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2022-08-16","symbol":"BPMUF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1660622400000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BPMUF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BPMUF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.4,"hold":0.2,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4,"analysts":5,"updateTime":1781150400000},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1427461,"yearFounded":2000,"employeeNum":189,"address":"Hegenheimermattweg 167b,Allschwil,Switzerland","zipCode":"4123","officePhone":"41 61 606 11 11","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.basilea.com/","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.0458},{"period":"3month","weight":0.1353},{"period":"6month","weight":-0.0708},{"period":"1year","weight":-0.15},{"period":"ytd","weight":0.072}],"description":"Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union. It also offers medicine drug for invasive fungal infections. In addition, the company provides Zevtera, an antibiotic for the treatment of community and hospital-acquired pneumonia, as well as offers treatment of acute bacterial skin and skin structure infections, and Staphylococcus aureus bacteremia. Further, it offers Fosmanogepix, an antifungal drug for the treatment of Candidemia which in Phase II clinical trials. Basilea Pharmaceutica AG was founded in 2000 and is headquartered in Allschwil, Switzerland.","exchange":"PINK LIMITED","name":"Basilea Pharmaceutica AG","nameEN":"Basilea Pharmaceutica AG"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"BPMUF\",market:\"US\",,,undefined,":null}}